Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 51, Issue 6, 2008, Pages 824-825

  Wu, Shu Fen ^a   Chen, An Chyi ^a   Peng, Ching Tien ^a,b   Wu, Kang Hsi ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

Author keywords

Acute lymphoblastic leukemia; L asparaginase; Octreotide; Pancreatitis

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ASPARAGINASE; METHOTREXATE; OCTREOTIDE;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE PANCREATITIS; ADOLESCENT; ARTICLE; ASPARAGINASE ASSOCIATED PANCREATITIS; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CONTINUOUS INFUSION; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESCHERICHIA COLI; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOCYST; TREATMENT DURATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; OCTREOTIDE; PANCREATITIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME;

EID: 56749151156     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21721     Document Type: Article

References (16)

1. Land VJ, Sutow WW, Fernbach DJ, et al. Toxicity of L- asparaginase in children with advanced leukemia. Cancer 1972;30:339-347.
2. Oettgen HF, Stephenson PA, Schwartz MK, et al. Toxicity of E. coli L-asparaginase in man. Cancer 1970;25:253-278.
3. McLean R, Martin S, Lam-Po-Tang PR. Fatal case of L-asparaginase induced pancreatitis. Lancet 1982;2:1401-1402.
4. Adrian TE, Barnes AJ, Long RG, et al. The effect of somatostatin analogs on secretion of growth, pancreatitis and gastrointestinal hormones in man. J Clin Endocr Metab 1981;52:675-681.
5. Lin WY, Liu HC, Yeh TC, et al. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;50:523-527.
6. Oettgen HF, Stephenson PA, Schwartz MK, et al. Toxicity of E. coli L-asparaginase in man. Cancer 1970;25:253-278.
7. Shaw MT, Barnes CC, Madden FJ, et al. L-Asparaginase and pancreatitis. Lancet 1970;2:721.
8. Robert MW, Robert LB. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. Cancer 1974;34:780-785.
9. Knoderer HM, Robarge J, Flockhart DA. Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer 2007;49:634-639.
10. Buchler MW, Binder M, Freiss H. Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis. Gut 1994;35:S15-S19.
11. Binder M, Uhl W, Freiss H, et al., Octreotide in the treatment of acute pancreatitis: Results of a unicenter prospective trial with three different octreotide dosages. Digestion 1994;55:20-23.
12. Raptis SA, Ladas SD. Therapy of acute pancreatitis with somatostatin. Scand J Gastroenterol Suppl 1994;207:34-38.
13. Choi TK, Mok F, Zhan WH, et al. Somatostatin in the treatment of acute pancreatitis: A prospective randomized controlled trial. Gut 1989;30:223-227.
14. Garrington T, Bensard D, Ingram D, et al. Successful management with octreotide of a child with L-asparaginase induced hemorrhagic pancreatitis. Med Pediatr Oncol 1998;30:106-109.
15. Lee C, Cheung YFW, Chan CF, et al. Somatostatin therapy in L-asparaginase-induced pancreatitis. Med Pediatr Oncol 1994;22:421-424.
16. Sahu S, Saika S, Pai SK, Advani SH. L-Asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1998;15:533-538.